Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Highland Small-Cap Equity Fund Class A (HSZAX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund seeks to achieve its investment objective by investing at least 80% of its net assets under normal circumstances in equity securities, such as common and preferred stocks, of small-cap companies, plus borrowing for investment purposes. The managers define a small-cap company as one with a market capitalization that falls between (a) the bottom range of the Russell 2000  Index ("Russell 2000 Index") and (b) the greater of either the top range of the Russell 2000 Index or $3.0 billion.


1 month+1.85% 3 years+11.36%
3 months+5.75% 5 years+13.63%
1 year+20.41% Since inception+10.48%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+13.63%+10.73%
Expense ratio2.02%1.31%
Risk 5 year sharpe ratio0.900.78
Net assets$61.0M$917.8M
Average market cap$1.8B$3.3B
Average P/E17.828.5
Portfolio turnover107%107%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyHighland Funds
Fund manager & tenureJames Dondero / 1 Years
Minimal initial investment$1,000.00
Minimum IRA investment--


U.S. stock97.42%
International stock2.58%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 15.20%
Healthcare 13.69%
Financial service 12.40%
Consumer goods 10.64%
Business service 9.24%
Top 10 Holdings
Portfolio weighting
JCAP Jernigan Capital Inc6.54%
PDCO Patterson Companies Inc4.00%
RARE Ultragenyx Pharmaceutical Inc3.71%
PCRX Pacira Pharmaceuticals Inc3.38%
IRT Independence Realty Trust Inc3.30%
RAS RAIT Financial Trust3.28%
WTW Weight Watchers International Inc3.12%
FIG Fortress Investment Group LLC2.87%
ETE Energy Transfer Equity LP2.74%
PTLA Portola Pharmaceuticals Inc2.57%